# Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study

> **NCT04893031** · — · COMPLETED · sponsor: **Karadeniz Technical University** · enrollment: 213 (actual)

## Conditions studied

- Tocilizumab
- COVID-19
- Critical Care
- Mortality

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT04893031
- **Lead sponsor:** Karadeniz Technical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2021-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893031, "Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04893031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*